Stay updated on Mepolizumab Clinical Trial for HES & Severe Asthma
Sign up to get notified when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.

Latest updates to the Mepolizumab Clinical Trial for HES & Severe Asthma page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference3%

- Check28 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now shows revision v3.0.2 (up from v3.0.1), and the Back to Top link has been removed.SummaryDifference0.2%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a reference to a long-term safety study on mepolizumab for severe asthma. Notably, the term 'Hypereosinophilic syndrome' has been added, while several related terms and previous location details have been removed.SummaryDifference3%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab Clinical Trial for HES & Severe Asthma
Enter your email address, and we'll notify you when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.